Improving Veteran Health by Increasing Dental Stewardship of Antibiotics and Opioids
Improving Veteran Health by Increasing Dental Stewardship of Antibiotics and Opioids
批准号:
10186541
负责人:
KJ Suda
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-03-31
关键词:
AcuteAdverse drug eventAdvisory CommitteesAmericanAmerican Dental AssociationAntibiotic ProphylaxisAntibiotic ResistanceAntibioticsAreaAttitudeAwarenessBehaviorCaringCategoriesCharacteristicsClostridium difficileCodeCommunitiesDataDatabasesDentalDental CareDentistsDevelopmentDoctor shoppingDrug AddictionDrug PrescriptionsEvidence based practiceGoalsGuidelinesHealthHealthcareHourInfectionInfection Prophylaxis and ManagementInfective endocarditisInstitutesInterventionInterviewJoint ProsthesisKnowledgeLeadLinkMedicalMethodsOpioidOutcome StudyOutpatientsPain managementPatient-Centered CarePatientsPatternPerceptionPharmaceutical PreparationsPrivate SectorProphylactic treatmentProviderRQ2RecommendationResearchResearch PriorityResistanceRiskSafetySecondary toSerious Adverse EventShipsSourceTestingTherapeuticToothacheUpdateVeteransViralVisitVulnerable Populationsantimicrobialbacterial resistancebasedental infectiondrug misuseevidence baseimplementation scienceimplementation studyimprovedinnovationjoint infectionmedical specialtiesmedication safetynon-opioid analgesicnovelopioid epidemicopioid misuseopioid overdoseopioid usepathogenpatient safetypopulation healthprescription monitoring programprescription opioidprovider behaviorrespiratoryrisk perceptionsubstance usertreatment guidelines
中文摘要
抗生素和阿片类药物是牙医开出的首选治疗类别。有趣的是,相关因素
英文摘要
Antibiotics and opioids are the top therapeutic categories prescribed by dentists. Interestingly, factors associ-
ated with prescribing behaviors of these medication classes are similar. Our preliminary data on dental pre-
scribing demonstrates that 1) high prescribers of opioids are also high prescribers of antibiotics and 2) over-
prescribing of antibiotics and opioids is common. However, there is a knowledge gap in our understanding of
medication prescribing and overprescribing (for inappropriate indications and/or excessive quantity/potency/
duration) by dentists. This gap is significant because dentists prescribe 1 out of every 10 prescriptions (Rx)
for both antibiotics and opioids in the US. Inappropriate and appropriate use of antibiotic and opioids are a
risk to patient safety, including: bacterial resistance, C. difficile infection (CDI), opioid overdose, drug de-
pendence and diversion. Opioid overprescribing is concerning because substance users commonly seek
opioids from dentists, dentists infrequently use prescription drug monitoring programs (PDMP) and fatalities
secondary to opioid use have been linked to dental prescribing. Use of antibiotics for infection prophylaxis
prior to dental procedures has been associated with CDI. Guidelines for infective endocarditis and prosthetic
joint infection prophylaxis during dental procedures were recently updated, significantly reducing the number
of patients requiring antibiotic prophylaxis. However, despite infection prophylaxis being the primary indica-
tion for antibiotics prescribed by dentists, our national data shows only a small (0.7%) decrease in overall
dental antibiotic prescribing. Although efforts are increasing to curtail overuse of these medication classes,
most interventions are focused on medical providers. Guided by preliminary data, we will be pursuing 3 spe-
cific aims: 1) Assess dental prescribing of antibiotics and opioid medications and identify characteristics as-
sociated with high rates of inappropriate prescribing; 2) Describe dentists' attitudes towards prescribing anti-
biotics and opioids among those with high and low prescribing patterns in high and low prescribing facilities;
and 3) Develop a pilot implementation study to improve dental prescribing. The proposed study is aligned
with the research priority areas of HSR&D (healthcare equity-vulnerable populations; implementation sci-
ence-provider behavior; and patient-centered care-opioid use) and 2 White House National Action Plans fo-
cused on antibiotic resistance and adverse drug events. The goals of this collaborative project also align with
the priorities of our operational partners: VA Dental Services, PBM MedSafe, and the Antimicrobial Steward-
ship Task Force. We propose to conduct a mixed-methods study to assess antibiotic and opioid dental pre-
scribing based on American Dental Association recommendations and identify factors related to prescribing.
We will triangulate results from administrative data and interviews with `high' and `low'-prescribing dentists at
`high' and `low'-prescribing facilities. The expected outcomes of this study include providing baseline data on
the extent of antibiotic and opioid overprescribing by dentists, identification of barriers and facilitators to im-
proving prescribing of antibiotics and opioids and development of a pilot implementation project to improve
the quality of dental care. Additionally, VA provides a unique opportunity to study dental prescribing because
ICD9/10 coding by private sector dentists is rare. Thus, the impact of our results are likely to be far-reaching.
This research is innovative in that it will be the first study, to our knowledge, utilizing national VA databases
to answer research questions on dental prescribing of antibiotics and opioids. The goal of the proposed pro-
ject is to develop actionable findings for decision makers that can be implemented to improve evidence-
based prescribing of antibiotics and opioids by dentists. Our long-term goal is to improve Veteran dental care
by implementing interventions that will increase prudent antimicrobial use, decrease opioid overprescribing
and decrease serious adverse events. Simultaneously intervening on the misuse of antibiotics and opioids
may more efficiently improve evidenced-based care delivered by dentists.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1097/j.pain.0000000000002759
发表时间:
2023-04-01
期刊:
Pain
影响因子:
7.4
作者:
[]
通讯作者:
DOI:
10.1016/j.amepre.2022.01.023
发表时间:
2022-09
期刊:
AMERICAN JOURNAL OF PREVENTIVE MEDICINE
影响因子:
5.5
作者:
[Suda, Katie J., Evans, Charlesnika T., Gibson, Gretchen, Jurasic, M. Marianne, Poggensee, Linda, Gonzalez, Beverly, Hubbard, Colin C., Vivo, Amanda, Cunningham, Fran E., McGregor, Jessina C., Gellad, Walid F.]
通讯作者:
Gellad, Walid F.
DOI:
10.3389/fphar.2024.1249531
发表时间:
2024
期刊:
Frontiers in pharmacology
影响因子:
5.6
作者:
[Ramanathan S, Evans CT, Hershow RC, Calip GS, Rowan S, Hubbard C, Suda KJ]
通讯作者:
Suda KJ
DOI:
10.1017/ash.2022.242
发表时间:
2022
期刊:
Antimicrobial stewardship & healthcare epidemiology : ASHE
影响因子:
--
作者:
[Hughes, Ashley M, Evans, Charlesnika T, Fitzpatrick, Margaret A, Kale, Ibuola O, Vivo, Amanda, Boyer, Taylor L, Solanki, Pooja A, Gibson, Gretchen, Jurasic, M Marianne, Sharp, Lisa K, Echevarria, Kelly L, Suda, Katie J]
通讯作者:
Suda, Katie J
DOI:
10.1017/ash.2022.18
发表时间:
2022
期刊:
Antimicrobial stewardship & healthcare epidemiology : ASHE
影响因子:
--
作者:
[Vivo, Amanda, Durkin, Michael J, Kale, Ibuola, Boyer, Taylor, Fitzpatrick, Margaret A, Evans, Charlesnika T, Jurasic, M Marianne, Gibson, Gretchen, Suda, Katie J]
通讯作者:
Suda, Katie J
共 8 条
The broken drug supply chain: The impact of COVID-19 on drug shortages and Veteran health
-
批准号:10637004
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:KJ Suda
-
依托单位:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
-
批准号:10676786
-
项目类别:
-
资助金额:$75.65万
-
财政年份:2022
-
负责人:KJ Suda
-
依托单位:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
-
批准号:10440970
-
项目类别:
-
资助金额:$79.35万
-
财政年份:2022
-
负责人:KJ Suda
-
依托单位:
Impact of COVID-19 on Drug Shortages
-
批准号:10362097
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:KJ Suda
-
依托单位:
Dental prescribing of antibiotics and opioids: high use in the absence of evidence
-
批准号:9753146
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:KJ Suda
-
依托单位:
Dental prescribing of antibiotics and opioids: high use in the absence of evidence
-
批准号:10166019
-
项目类别:
-
资助金额:$27.05万
-
财政年份:2017
-
负责人:KJ Suda
-
依托单位:
海外基金